h i g h l i g h t s
This study confirms an emotional face processing deficit in Huntington's disease (HD). This study demonstrates the electrophysiological underpinnings of the emotional processing deficit in HD. This study suggests that the emotional processing deficit in HD is caused by a generic visual processing deficit.
a b s t r a c t
Objective: This study aimed to characterise, emotion perception deficits in symptomatic Huntington's disease (HD) via the use of event-related potentials (ERPs). Methods: ERP data were recorded during a computerised facial expression task in 11 HD participants and 11 matched controls. Expression (scrambled, neutral, happy, angry, disgust) classification accuracy and intensity were assessed. Relationships between ERP indices and clinical disease characteristics were also examined. Results: Accuracy was significantly lower for HD relative to controls, due to reduced performance for neutral, angry and disgust (but not happy) faces. Intensity ratings did not differ between groups. HD participants displayed significantly reduced visual processing amplitudes extending across pre-face (P100) and face-specific (N170) processing periods, whereas subsequent emotion processing amplitudes (N250) were similar across groups. Face-specific and emotion-specific derivations of the N170 and N250 ('neutral minus scrambled' and 'each emotion minus neutral', respectively) did not differ between groups. Conclusions: Our data suggest that the facial emotion recognition performance deficits in HD are primarily related to neural degeneration underlying 'generalised' visual processing, rather than face or emotional specific processing. Significance: ERPs are a useful tool to separate functionally discreet impairments in HD, and provide an important avenue for biomarker application that could more-selectively track disease progression. Ó 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
With the development of up and coming drug trials in Huntington's disease (HD), there is an urgent need to identify potential biomarkers that can sensitively track disease progression and importantly that are functionally relevant (Georgiou-Karistianis et al., 2013a,b,c) . Previous studies have identified emotion perception deficits in premanifest HD (pre-HD) individuals 15 years prior to estimated onset (and in the absence of cognitive change), suggesting that emotion alterations may be one of the earliest quantifiable behavioural changes observed preclinically (Gray et al., 1997; Stout et al., 2011) . To this end further investigation of emotion perception in HD may offer new insights regarding early functional changes, which could provide an important avenue for biomarker development.
Specific emotion perception deficits in HD were initially documented by Sprengelmeyer et al. (1996) , who used six basic
